By MedClinRes.org Editorial Team
If you’ve been searching for whether CBD actually helps with sleep, here’s the direct answer: the clinical evidence so far is mixed and limited, and it does not show a clear, consistent, meaningful improvement in insomnia. A few small trials report modest benefits on some sleep measures, while a separate trial that used objective movement tracking rather than self-report alone found no significant difference from placebo on core insomnia outcomes. Below, we walk through what the research actually measured, where it disagrees, and what remains unknown about using CBD for sleep over the long term.
What the Research Actually Shows
Among the trials available on this question, the one with the most rigorous measurement is a 2024 randomized, placebo-controlled pilot trial published in the Journal of Clinical Sleep Medicine. Researchers gave 15 adults with moderate-to-severe primary insomnia 150 mg of CBD nightly, sublingually, for two weeks, and compared them to 15 adults on placebo. Instead of relying only on how participants described their sleep, the trial tracked it with wrist-actigraphy (a movement-sensing device) alongside sleep diaries. The result: insomnia severity, sleep-onset latency, sleep efficiency, and wake-after-sleep-onset did not differ between the CBD and placebo groups. The CBD group did report higher well-being scores, and a companion analysis from the same trial found daytime cognitive function was preserved and participants reported greater calmness — but on the specific question of whether CBD reduced insomnia, this trial came back negative.
Smaller, separately designed trials point the other direction. A 2025 randomized, double-blind, placebo-controlled crossover pilot study of a cannabinoid supplement in adults with subthreshold insomnia (20 participants, 10 days per condition) found statistically significant improvements in sleep quality, sleep efficiency, and insomnia symptom scores compared to placebo. These are promising signals, but the trial was small, short, and used a different formulation and population than the JCSM study — which is part of why a published review of CBD and sleep research describes the overall evidence base as still needing standardized formulations, objective measurement, and larger samples before firm conclusions can be drawn.
The honest summary: a handful of small trials disagree with each other. Some show no measurable benefit on standard insomnia endpoints; others show modest improvement on self-reported scales. Neither outcome has been confirmed in a large, independent trial.
What Remains Uncertain About Long-Term Use
Most of what we know about CBD and sleep comes from trials lasting two weeks or less. That leaves several open questions a short trial can’t answer:
- Durability. Whether any sleep benefit holds up, fades, or requires escalating doses after weeks or months of nightly use hasn’t been studied in a controlled trial.
- Withdrawal and rebound. There is no controlled research on what happens to sleep when long-term CBD use is stopped, including whether rebound insomnia occurs.
- Chronic insomnia versus short-term sleep complaints. The trials above enrolled people with primary or subthreshold insomnia for a matter of weeks. People with longstanding, treatment-resistant chronic insomnia were not specifically studied, so results may not generalize to that group.
- Safety with regular use. The FDA’s CBD safety communications flag liver injury, drug interactions, drowsiness, and reports of male reproductive toxicity in animal studies as areas of ongoing concern, and the agency has stated it does not yet have enough data to generally recognize CBD as safe for routine use. These concerns are based on the broader CBD safety literature, not sleep trials specifically, but they apply to anyone considering nightly long-term use.
- Interactions with sleep medication. None of the trials above tested CBD alongside prescription sleep aids, antidepressants, or other common medications — a real-world combination worth discussing with a prescriber before trying.
A Reader’s Evidence Grid: Benefits and Limits
If you’re trying to weigh what CBD research can and can’t tell you about your own sleep goal, it helps to separate these five questions:
- What’s the actual goal? “Falling asleep faster,” “staying asleep through the night,” and “feeling rested the next day” are different endpoints, and the trials above didn’t all measure the same ones.
- Who was studied, and in what form? The negative JCSM trial used 150 mg sublingual CBD isolate in people with diagnosed primary insomnia. The positive 2025 trial used a different cannabinoid supplement in people with milder, subthreshold symptoms. Results from one don’t automatically transfer to the other.
- What did the trial find, and how confident can you be? Objective measures (actigraphy) found no difference from placebo in the largest trial; subjective scales found improvement in a smaller one. Both are pilot-sized studies, so neither result is definitive.
- Could it interact with anything you’re already taking? CBD is processed by liver enzymes that also metabolize many common medications, which is why the FDA flags drug interactions as a specific concern.
- What’s a reasonable next step? For most readers, that’s a conversation with a doctor or pharmacist about your sleep history and current medications. It’s also worth knowing that cognitive behavioral therapy for insomnia (CBT-I) — not a supplement or a drug — is the treatment the American College of Physicians and the American Academy of Sleep Medicine both recommend as the first-line approach for chronic insomnia, with the best-studied track record of the options available.
The Bottom Line
CBD for sleep is an active area of research, not a settled one. The trial that measured sleep most rigorously found no objective improvement over placebo; a smaller, differently designed trial found a measurable one on self-reported scales. Until larger, independent trials resolve that disagreement, readers considering CBD for sleep are better served by treating it as unproven rather than assuming it works — and by bringing their full sleep history and medication list to a clinician before deciding whether to try it, rather than self-treating chronic insomnia alone.